The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction
Open accessPublished version of a preprint
Abstract
A SARS-CoV-2 variant B1.1.7 containing mutation Δ69/70 has spread rapidly in the United Kingdom and shows an identifiable profile in ThermoFisher TaqPath RT-qPCR, S gene target failure (SGTF). We analyzed recent test data for trends and significance. Linked cycle threshold (Ct) values for respiratory samples showed that a low Ct for ORF1ab and N were clearly associated with SGTF. Significantly more SGTF samples had higher inferred viral loads between 1×107 and 1×108. Our conclusion is that patients whose samples exhibit the SGTF profile are more likely to have high viral loads, which may explain higher infectivity and rapidity of spread.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was also associated with threefold to eightfold higher upper-airway levels [199][200][201]”
From The biological and clinical significance of emerging SARS-CoV-2 variants (2021) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., O’Toole, Á., et al. (2021) · doi:10.1101/2020.12.30.20249034 · Cited by 1,611
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Ferguson, J., Dunn, S. J., Best, A., Mirza, J. D., Percival, B. C., Mayhew, M., Megram, O., Ashford, F. B., White, T., Moles-Garcia, E., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001216 · Cited by 70
Self-citationHow to establish an academic SARS-CoV-2 testing laboratory
Richter, A. G., Plant, T. D., Kidd, M., Bosworth, A., Mayhew, M., Megram, O., Ashworth, F., Crawford, L., White, T., Moles-Garcia, E., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00818-3 · Cited by 22 · cited 1×
“4 Background: The UK response to the SARS-CoV-2 pandemic has involved the setup of high-throughput diagnostic centres [1] operationally standardised using commercial reverse-transcriptase qualitative polymerase chain reaction (RT-qPCR) testing [2].”
BackgroundSelf-citationFerguson, J., Dunn, S. J., Best, A., et al. (2020) · medRxiv · doi:10.1101/2020.12.01.20237784 · Cited by 17
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Richter, 24, Extrapolation of United Kingdom pillar 2 care home COVID-19 test data to ascertain effectiveness of lateral flow testing in low prevalence settings, medRxiv
Cited by
Sorted by citations
Items 201–237 of 237
COVID-19 mass testing and sequencing: Experiences from a laboratory in Western Kenya
Waitumbi, J. N., Omuseni, E., Nyataya, J., Masakhwe, C., Sigei, F., Lemtudo, A. P., Awinda, G., Muthanje, E. M., Andika, B., Githii, R., et al. (2022) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v11i1.1737 · Cited by 1
Miller, M. R., Tkachenko, A., Guag, J., Alexander, S., Webb, B. T., & Stenger, B. L. S. (2024) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/10406387241230315 · Cited by 1
Nussbaum, E. Z., Thiriveedhi, V., Uddin, R., Cho, H. E., Carroll, S., Rosenberg, E. S., Lemieux, J. E., & Turbett, S. E. (2022) · Annals of Internal Medicine · doi:10.7326/m22-0023 · Cited by 1
Keita, I., Dabo, G., Doumbia, L., Diarra, Y., Traoré, I., Traoré, M., Sangaré, L., Toloba, Y., Diallo, M. A., Sy, D., et al. (2022) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2022.1111065 · Cited by 1
Diabelko, D., Dvořáčková, M., Dvořáková, M., Forte, G., Čundrle, I., Růžička, F., & Vrbský, J. (2021) · medRxiv · doi:10.1101/2021.05.24.21257365 · Cited by 1
Second-Generation Antibodies Neutralize Emerging SARS-CoV-2 Variants of ConcernPreprint
Kovačech, B., Fialova, L., Filipcik, P., Škrabana, R., Zilkova, M., Paulenka-Ivanovova, N., Kováč, A., Palova, D., Rolkova, G. P., Tomková, K., et al. (2021) · bioRxiv · doi:10.1101/2021.06.09.447527
Russell, A., O’Connor, C., Lasek‐Nesselquist, E., Plitnick, J., Kelly, J. P., Lamson, D. M., & George, K. S. (2021) · medRxiv · doi:10.1101/2021.09.14.21262977 · Cited by 1
Ashford, F. B., Best, A., Dunn, S. J., Ahmed, Z., Siddiqui, H., Melville, J., Wilkinson, S., Mirza, J. D., Cumley, N., Stockton, J., et al. (2021) · medRxiv · doi:10.1101/2021.11.17.21266297 · Cited by 1
“was associated with significantly higher viral loads (17), and had a genotyping assay”
BackgroundSelf-citationA Hybrid SEIHCRDV-UKF Model for COVID-19 Prediction. Application on real-time dataPreprint
Papageorgiou, V. Ε., & Tsaklidis, G. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1816184/v1 · Cited by 1
Lee, S., Grujic, S., Modern, S., Wann, A., Fraser, D. P., & Percival, B. C. (2023) · medRxiv · doi:10.1101/2023.06.03.23289684 · Cited by 1
Self-citationAmpliconTyper – tool for analysing ONT multiplex PCR data from environmental and other mixed sourcesPreprint
Spadar, A., Mahindroo, J., Troman, C. M., Owusu, M., Adu‐Sarkodie, Y., Owusu-Dabo, E., Abraham, D., Benny, B., Govindan, K., Mohan, V. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.30.635642 · Cited by 1
Couzens, A., Murrell, I., Gifford, L., Johns, B., Pheasant, K., Turner, L., Evans, J., & Moore, C. (2021) · medRxiv · doi:10.1101/2021.04.02.21254832
Borley, D. W., Trevor, R. A., Richter, A. G., Kidd, S. P., Cortes, N., Moore, N. A., Goring, A., Templeton, K. E., Teltumbde, P., Grippon, S., et al. (2021) · medRxiv · doi:10.1101/2021.05.05.21256396
Self-citationKidd, M., & Atabani, S. F. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab304
Self-citationPolechová, J., Kd, J., Payne, P., Crozier, A. F. F., Beiglböck, M., Plevka, P., & Schernhammer, E. S. (2021) · arXiv (Cornell University)
Vidya, N., Kumaresan, A., Kalaivani, V., Kumar, A., Gurunathan, S., Selvi, R. A., Uma, R., Varsha, P., Raju, S., Sampath, P., et al. (2021) · medRxiv · doi:10.1101/2021.12.14.21251883
Bailey, S. F., & Akter, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-1356-3_5
A Hybrid SEIHCRDV-UKF Model for COVID-19 Prediction. Application on real-time dataPreprint
Papageorgiou, V. Ε., & Tsaklidis, G. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1816184/v2
Emergence of SARS CoV-2 Variant B.1.1.7 in a Pandemic Hospital
Bilgin, M., Taşkın, M. H., Özgen, E., & Yavuz, D. (2022) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20229607
"Can the Following Strategy Generate a Definitive Anti-Covid Vaccine?"
Gennaro, C. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.42.006753
Gaskell, K. M., Elkheir, N., Mirfendesky, M., Rampling, T., Marks, M., Houlihan, C. F., Lemonge, N., Bristowe, H., Aslam, S., Kyprianou, D., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284372
“contact age – median (IQR) 25 (12-45) 42 (24-60)”
Characterization and Resistance to Mutation of a Single-Channel Multiplex PCR Assay for SARS-CoV-2Preprint
Pednault, A. L., & Swalla, B. M. (2023) · medRxiv · doi:10.1101/2023.04.27.23289205
Copper coordination-driven self-assembly and encapsulation of PCR reagents
Lu, C., Zheng, J., & Liu, J. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108808
Epidemiological Characteristics of SARS-CoV-2-Positive Samples in Japan: A Retrospective Study
Tadokoro, K., Miki, K., Yamasaki, T., Yamaguchi, T., Tateda, K., Kondo, K., & Arai, N. (2023) · Current Trends in Internal Medicine · doi:10.29011/2638-003x.100098
Multiplex qPCR Discriminates Variants of Concern to Enhance Global Surveillance of SARS-CoV-2
Vogels, C. B. F., Breban, M. I., Ott, I. M., Alpert, T., Petrone, M. E., Watkins, A. E., Kalinich, C. C., Earnest, R., Rothman, J. E., de Jesus, J. G., et al. (2023) · doi:10.1201/9781003298038-30
Ayran, J., Köhler, C., Linh, L. T. K., Schneider, G., Pallerla, S. R., Battke, F., Federle, L., Martus, P., Kremsner, P. G., & Velavan, T. P. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1159622
Current Progress in Genomic and Genetic Research on Human Viral Diseases
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4833-2 · Cited by 1
21.1 In Focus: The Impact and Mechanisms of Superspreading
Nielsen, B. F., Sneppen, K., & Simonsen, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-48408-7_31
Duesterwald, L., Nguyen, M., Christensen, P. A., Long, S. W., Olsen, R. J., Musser, J. M., & Davis, J. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312686 · Cited by 2
Akçeşme, F., Köprülü, T., Çam, B. E., Is, S., Keskin, B., Akcesme, B., Baydili, K., Gezer, B., Balkan, J., Uçar, B., et al. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10962-8
“However, extensive studies concerning global genetic diversity and conserved regions of the viral genome must be carried out, not only to develop epitope-based vaccines, but also to develop qPCR-kits and thus to be able to identify the virus in a much more specific manner (Kidd et al. 2021).”
Chen, Z., Cheng, Q., Mu, X., Liu, Y., Zhang, M., Tian, D., Huang, Y., Bai, X., Yang, Y. F., & Li, Q. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70502
How to stay safe with a fast-spreading new coronavirus variant on the loose
Dhaniyala, S., & Erath, B. D. (2021) · doi:10.64628/aai.s75ywrtp5
Spadar, A., Mahindroo, J., Troman, C. M., Owusu, M., Adu‐Sarkodie, Y., Owusu-Dabo, E., Abraham, D., Benny, B., Govindan, K., Mohan, V. R., et al. (2025) · Microbial Genomics · doi:10.1099/mgen.0.001421
“By multiplexing both primer sets and samples, the lab costs are further reduced with the additional benefit of primer multiplexing giving improved sensitivity and specificity of organism detection due to simultaneous detection of multiple genetic regions from a single target organism [5, 6].”
Early response model for containing newly emerging infectious diseasesPreprint
Dekens, M. P. S., Neumann, T., Micheler, T., Gandhi, V., Kellner, M. J., Rocha-Hasler, M., Weißenböck, M., Fellner, M., Al-Rawi, M., Beer, N., et al. (2025) · medRxiv · doi:10.1101/2025.10.14.25337721
Rakotondramanga, J. M. (2023) · theses.fr (ABES) · doi:10.70675/aae0cc9az3b0fz4ccdzb05az583a89448b7d
Choudhary, M. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-26000-0_10
Development of an Agnostic Clinical Metagenomic Workflow for Respiratory RNA VirusesPreprint
Dingle, K. E., Hopkins, K. M. V., Sanderson, N. D., Vaughan, A., Anderton, D., Colpus, M., Parker, M., Fatima, S. A., Gentry, J., Dunn, L., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10471119/v1
Metadata
- Authors
- Kidd, M., Richter, A., Best, A., Cumley, N., Mirza, J., Percival, B., Mayhew, M., Megram, O., Ashford, F., White, T., Moles-Garcia, E., Crawford, L., Bosworth, A., Atabani, S. F., Plant, T., & McNally, A.
- Affiliations
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Birmingham (GB)
- Corresponding author
- Kidd, Michael
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-02-13
- Volume
- 223
- Issue
- 10
- Pages
- 1666-1670
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC7928763
- OpenAlex
- W3128016658
- Cited by
- 237
- References
- 3
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 12 · 2023: 31 · 2022: 67 · 2021: 116
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- UK Department of Health and Social Care
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, B.1.1.7 variant, S-gene target failure, viral load, cycle threshold, ORF1ab, N gene, infectivity, COVID-19 diagnosis
- MeSH terms
- COVID-19, SARS-CoV-2, Humans, Linear Models, Polymerase Chain Reaction, Viral Load, Taq Polymerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review